Formerly known as nonalcoholic fatty liver disease, this condition affects 1 in 4 people worldwide. Among those with type 2 ...

Nonalcoholic fatty liver disease (NAFLD) and its more severe form NASH are common liver diseases in industrialized countries. Diabetes, obesity, the metabolic syndrome and NAFLD all share common ...

diabetes mellitus, liver disease or chronic kidney disease at baseline). Retrospective cohort studies were not included.

New research from Karolinska Institutet in Sweden highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye disease.

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of liver disease worldwide. NAFLD is commonly associated with the metabolic syndrome ('Metabolic NAFLD' and predisposes to more ...

At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease ... dysfunctions—including obesity, diabetes mellitus and metabolic syndrome—that are now ...

"Patients with metabolic-associated steatohepatitis (MASH) also showed higher LDH levels. LDH levels were positively linked ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 ...